{"id":"W4396900273","doi":"10.1002/cac2.12547","title":"Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study","year":2024,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Apatinib; Medicine; Oncology; Cervical cancer; Internal medicine; Overall survival; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001787377,0.0003414688,0.0006560108,0.0002316992,0.0002175061,0.00005518772,0.000343054,0.00007399668,0.0001107618],"category_scores_gemma":[0.00002802583,0.0001855871,0.00007144336,0.001280165,0.0001918385,0.0001528303,0.0001933443,0.0004879127,0.000003235991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001071275,"about_ca_system_score_gemma":0.0003167828,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005817081,"about_ca_topic_score_gemma":0.02252824,"domain_scores_codex":[0.9980333,0.0002160158,0.0005322366,0.0004487179,0.0004409906,0.0003287448],"domain_scores_gemma":[0.9981623,0.0002688828,0.0001077263,0.001207592,0.0001298051,0.0001236956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003255424,0.005162072,0.9479083,0.00008874305,0.0004701701,0.00005239557,0.004286186,0.00001827894,0.00001430537,0.00003514921,0.000005482093,0.03870343],"study_design_scores_gemma":[0.04019564,0.004569119,0.9526131,0.0007237283,0.0004917227,0.000003036546,0.0008844027,0.00006183865,0.00006030144,0.000008758258,0.0001717726,0.0002165863],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840896,0.009333777,0.000003538445,0.003068133,0.00009503186,0.002730791,0.0001453299,0.00006447482,0.0004692995],"genre_scores_gemma":[0.9949772,0.00143181,0.00009628836,0.0001458361,0.00003610854,0.002885938,0.0002238128,0.00004531031,0.0001576847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03848685,"threshold_uncertainty_score":0.9953081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03813081594581162,"score_gpt":0.3588766162722905,"score_spread":0.3207458003264789,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}